Obesity: disease and predictor of health complications
DOI:
https://doi.org/10.32782/2077-6594/2025.4/04Keywords:
obesity, complications of obesity, laboratory parametersAbstract
Obesity leads to structural and functional changes that culminate in numerous organ-specific pathological complications, significantly affecting morbidity as well as the quality and length of life of obese individuals. The aim of the study was to determine the prevalence of complications associated with obesity. Payer, Jackuliak, and Nagyová [8] point to an association between obesity and the development of several malignant tumors, particularly breast, colorectal, and prostate cancer. Kováčová and Dókuš [9] suggest that pregnant women with obesity are also exposed to a higher risk of maternal and perinatal complications, with the risk increasing as BMI rises. Skin folds formed as a result of obesity and sweating induce skin inflammation, fungal infections, and eczema. Materials and methods. Data were collected using a questionnaire and bioimpedance measurement with the InBody 230 device, with an emphasis on gender differences. Biochemical parameters were determined using standard laboratory methods in cooperation with the Alpha Medical laboratory. The obtained data were analyzed using descriptive and inferential statistics. The data were evaluated using both descriptive and inferential statistics. In descriptive statistics, absolute (f) and relative frequencies (%) were used. For interval (continuous) variables, the arithmetic mean (AM), standard deviation (SD), median (Mdn), as well as minimum (min) and maximum (max) values were applied. Inferential statistics included tests for group comparisons and for identifying relationships between variables. Prior to selecting an appropriate test, data normality was assessed using the Kolmogorov–Smirnov test. As normality was not confirmed in all cases, non-parametric tests were employed. The Kruskal–Wallis test was used to compare multiple groups within a single variable. For nominal variables, the chi-square test of independence and the chi-square goodness-of-fit test were applied. When the assumptions for these tests were not met (expected frequencies < 5), Fisher’s exact test was used. The degree of association was evaluated using Spearman’s rank correlation. The level of significance was set at α = 0.05. Cohen’s d was used to determine the practical significance of relationships. Values close to dCohen = 0.2 are considered small, around 0.5 medium, approximately 0.8 large, and above 0.8 very large. In the case of Spearman’s correlation, the correlation coefficient itself indicates the effect size. Results. A statistically significant difference between men and women was found in the presence of skin diseases (χ²(1)=5.823, p=0.016). Among women (n=27), the prevalence of skin diseases was higher than among men (n=7). A statistically significant difference between men and women was also observed in the presence of spinal and joint diseases (χ²(1)=6.321, p=0.012). Differences were also identified in the prevalence of respiratory diseases (χ²(1)=6.757, p=0.009), which were more frequent in women (n=37) than in men (n=11). In selected laboratory parameters, a decrease in body weight in cases of elevated values does not always result in a significant shift toward normal ranges. Conclusions. The prevalence of obesity is increasing worldwide and leads to structural and functional changes. It reduces average life expectancy. In patients with class III obesity (BMI ≥ 40 kg/m²), life expectancy is reduced by approximately 8–10 years. In patients with a BMI of 30–35 kg/m², life expectancy is shorter by about 3 years, and with each additional increase in BMI of 5 kg/m², the risk of vascular mortality due to conditions such as ischemic heart disease, stroke, and other vascular diseases increases by 40%. Despite this, obesity is not considered a disease.Obesity should be regarded as a chronic disease as well as a risk factor for the development of other serious chronic conditions. Information on the number of overweight/obese individuals and their comorbidities constitutes a fundamental basis for disease prevention and the prevention of disability. Such information is of great importance for the planning and development of public health policy, as well as for general public health activities and preventive measures.
References
Kahan S, Zvenyach T. Obesity as a disease: current policies and implications for the future. Current Obesity Reports. 2016;5(3):291–297. https://doi.org/10.1007/s13679-016-0218-7
Trnková Ľ, Fábryová M. Starostlivosť o dospelého pacienta s nadhmotnosťou/obezitou – edukácia sestrou. In: Odvrátiteľné riziká chorôb obehovej sústavy, edukácia sestrou. 1st ed. Štrba (Slovensko): Infodoktor; 2020. p. 163–177.
Kunešová M, et al. Základy obezitologie. Praha: Galén; 2016.
Trnková Ľ. Obezita je problémom zdravia, kvality a dĺžky života. 1. časť. Teória a prax: farmaceutický laborant. 2019;8(1):24–25.
Hainer V, et al. Základy klinické obezitologie. 3rd ed. Praha: Grada Publishing; 2022.
Fábryová Ľ. Epidemiológia a zdravotné dôsledky obezity. Via practica. 2015;12(1):8–14.
Sucharda P. Zdravotní rizika obezity a nemoci komplikující obezitu. In: Kunešová M, et al., editors. Základy obezitologie. Praha: Galén; 2016. p. 17–24.
Kováčová A, Dókuš K. Vplyv preobezity a obezity na gynekologické ochorenia. Forum diabetologicum. 2023;12(3):85–90.
Bartl I. Obezita z pohľadu andrológa. Via practica. 2024;21(4):146–150.
Trnková Ľ. The significance of anthropometric indicators in the prediction of abdominal obesity. Clinical Social Work and Health Intervention. 2019;10(4):25–32.
Hrušovský Š, Žigrai M, Rychlý B. Obezita a nealkoholová tuková choroba pečene. In: Klinická obezitológia. Brno: Facta Medica; 2013. p. 215–222.
Mucska I. Syndróm spánkového apnoe obštrukčného typu a obezita. Via practica. 2016;13(6):238–241.
Svačina Š. Obezita a ortopedické operace aneb existují mechanické komplikace obezity? Vnitřní lékařství. 2015;61(6):571–573.
Xu X, Li X, Wu W. Association between overweight or obesity and lumbar disk diseases: a meta-analysis. Journal of Spinal Disorders and Techniques. 2015;28(10):370–376. https://doi.org/10.1097/BSD.0000000000000235
Samartzis D, et al. A population-based study of juvenile disc degeneration and its association with overweight and obesity, low back pain, and diminished functional status. The Journal of Bone and Joint Surgery American Volume. 2011;93(7):662–670. https://doi.org/10.2106/JBJS.I.01568
Shiri R, et al. The association between obesity and low back pain: a meta-analysis. American Journal of Epidemiology. 2010;171(2):135–154. https://doi.org/10.1093/aje/kwp356
Zhang TT, et al. Obesity as a risk factor for low back pain: a meta-analysis. Clinical Spine Surgery. 2018;31(1):22–27. https://doi.org/10.1097/BSD.0000000000000468
Chou L, et al. The association between obesity and low back pain and disability is affected by mood disorders: a populationbased, cross-sectional study of men. Medicine (Baltimore). 2016;95(15):e3367. https://doi.org/10.1097/MD.0000000000003367
Frühbeck G, et al. European Association for the Study of Obesity position statement on the global COVID-19 pandemic. Obesity Facts. 2020;13:292–296. https://doi.org/10.1159/000508082
Popkin BM, et al. Individuals with obesity and COVID-19: a global perspective in epidemiology and biological relationship. Obesity Reviews. 2020;21(11):e13128. https://doi.org/10.1111/obr.13128
Diker D, Bettini S, Farpour-Lambert N, et al. Obesity and COVID-19: the two sides of the coin. Obesity Facts. 2020;13(4):430–438. https://doi.org/10.1159/000510005
Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiological and biological mechanisms. Archives of Physiology and Biochemistry. 2008;114:71–83.
Allemann Y, et al. Increased central body fat deposition precedes a significant rise in blood pressure in male offspring of essential hypertensive parents: a 5-year follow-up study. Journal of Hypertension. 2001;19:2143–2148.
Avdičová M, et al. Monitorovanie rizikových faktorov chronických chorôb v SR. Banská Bystrica: Regionálny úrad verejného zdravotníctva; 2012.
Fábryová Ľ. Diabetes mellitus a obezita (diabezita) a COVID-19. Via practica. 2022;19(4):146–152.
Belovičová M, Matula P. Účinnosť nefarmakologickej liečby obezity. Cardiology Letters. 2017;26(3):138–144.
Grassi D, et al. Chronic hyperuricemia, uric acid deposit and cardiovascular risk. Current Pharmaceutical Design. 2013;19(13):2432–2438.
Trnková Ľ. Pohybová aktivita ako jeden z pilierov v prevencii a liečbe nadváhy a obezity. Prohuman. 2025;(1):1–10. Available from: https://www.prohuman.sk/osetrovatelstvo/pohybova-aktivita-ako-jeden-z-pilierov-v-prevencii-a-liecbe-nadvahy-aobezity
Vansač P., Kenderešová, E. 2024. Etické problémy človeka s civilizačným ochorením, In: BABEČKA J., BERETA M., ZASTKO, L., (Eds.) Ružomberské zdravotnícke dni 2024 – XVIII. ročník Zborník z medzinárodnej vedecko-odbornej konferencie, VERBUM – vydavateľstvo KU, Ružomberok 2024, s. 221 – 229.
Vansač, P., Noga, V. Spiritual accompaniment of patients in palliative cere affected by the Covid – 19 pandemic, Acta Missiologica, vol. 15, no. 2, 2021, p. 213 – 233, ISSN: 2453-7160 (online) (October, 2021)







